MedTrace Logo

Sleep and Performance in Surgeons

NCT06213246 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2024-01-19

No results posted yet for this study

Summary

The primary aim of this study is to assess the changes in strength expression resulting from the performance of a surgical operation among orthopedic surgeons at the IRCCS Galeazzi-Sant'Ambrogio Hospital. To achieve this goal, the assessment of strength expression will be conducted using handgrip measurements before (pre) and after (post) the surgical operation. Additionally, both pre- and post-surgery, there will also be evaluations of changes in actigraphic sleep parameters, salivary cortisol levels, cognitive performance, and subjective perception levels of effort and drowsiness.

Te second aim is to assess differences in strength expression, cognitive performance, salivary cortisol levels, perceived effort, and drowsiness levels among surgeons in response to sleep hygiene strategies (week 2 vs week 3).

Conditions

  • Sleep

Interventions

BEHAVIORAL

Sleep Hygiene Strategies

The sleep hygiene strategies will be applied for all seven days of Week 3 and will involve the following guidelines recommended by the National Sleep Foundation * Maintain a consistent wake-up and bedtime schedule during workdays. * Do not delay/advance excessively (no more than 2 hours) the wake-up and bedtime - schedule during weekends. * Keep the bedroom temperature below 22°C. * Avoid sources of light and noise in the bedroom. * Use the bed only for sleeping, avoiding other activities before bedtime. * Avoid daytime naps during workdays. * Refrain from using electronic devices (PC, laptop, cellphone, television) at least 30 minutes before bedtime. * Expose yourself to natural light in the morning and reduce artificial lights in the evening. * Avoid consuming alcoholic beverages and caffeine in the afternoon. * Have a moderately sized dinner at least 3 hours before bedtime.

Sponsors & Collaborators

  • I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
23 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-10-23
Primary Completion
2024-12-23
Completion
2024-12-23

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06213246 on ClinicalTrials.gov